We have previously described the dominant expression patterns among multiple ICRs on TILs and shortlisted PD-1 and Tim-3 as the key ICRs on TILs which may associate with clinical outcomes in multiple types of cancer (22). This evidence concerns the gene PDCD1 and cancer.